Clinical Trial Update: Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial at the University of Alabama at Birmingham is evaluating advanced PET/MRI to monitor neoadjuvant treatment in HER2-positive breast canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: HER2-positive Breast Cancer | Phase 1 | Status: RECRUITING